
Weekly Phone Calls With Diabetes Educators Help Kids With Type 1 Diabetes Control Blood Sugar Better
A new study found that pediatric patients who received weekly telephone consultations about their diabetes had better blood sugar control and fewer complications than those who only saw their doctor at regular clinic visits.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- Children who had weekly phone check-ins with diabetes educators achieved lower average HbA1c levels (a measure of long-term blood sugar control) compared to those receiving standard clinic-based education
- The telemonitoring group experienced fewer dangerous blood sugar emergencies called diabetic ketoacidosis (DKA) and had lower rates of complications like protein in urine and abnormal cholesterol levels
- Patients in the telemonitoring group reported better quality of life scores, suggesting the extra support made a meaningful difference in how they felt day-to-day
- This study suggests telehealth approaches may offer real benefits for managing Type 1 diabetes in children, especially for families who face barriers to regular in-person clinic visits
What the Study Looked At
Researchers compared two approaches to diabetes education for children with Type 1 diabetes. One group of 70 children received weekly telephone consultations with diabetes educators, while a second group of 70 children received standard diabetes education during routine visits to an outpatient clinic. Both groups were followed for six months, and researchers measured their blood sugar control, complications, and quality of life.
Weekly Phone Support Led to Better Blood Sugar Control
The children who received weekly phone consultations had significantly better glycemic control. Their average HbA1c was 8.21 compared to 9.25 in the standard care group. During these calls, educators reviewed blood glucose records, discussed eating patterns, and helped families adjust insulin doses as needed.
More importantly, the telemonitoring group experienced far fewer serious blood sugar emergencies. Only 1.7% of children in the phone consultation group had a diabetic ketoacidosis episode, compared to 18% in the standard care group—a substantial difference that reflects better overall management.
Fewer Complications Over Six Months
Children in the telemonitoring group also developed fewer diabetes-related complications during the study period. Complications including lipodystrophy (fat deposits from injection sites), proteinuria (protein in urine), and dyslipidemia (abnormal cholesterol) occurred in 15.5% of the intervention group versus 37.7% of the standard care group.
These results suggest that the extra oversight and guidance provided through weekly phone calls may help prevent some of the complications that can develop when blood sugar remains high over time.
Quality of Life Improved With Telemonitoring
Beyond numbers on lab reports, children and families in the telemonitoring group reported significantly better quality of life. This finding matters because managing Type 1 diabetes is not just about achieving good numbers—it's about doing so in a way that feels sustainable and doesn't overwhelm families with daily life.
The study suggests that having regular, accessible contact with diabetes educators through phone calls may reduce stress and make families feel more supported in their diabetes care.
What This Means for Diabetes Care
This research adds evidence that telehealth approaches can be an effective tool for managing Type 1 diabetes in children. Weekly telephone consultations do not replace the need for regular medical care from a diabetes team, but they appear to enhance it by providing more frequent check-ins and opportunities to adjust management.
For families who struggle to attend regular clinic visits due to distance, work schedules, or other barriers, telemonitoring offers a promising way to get more frequent support. However, this study represents research from one center over six months, and more evidence would help determine how well these benefits hold over longer periods and in different settings.
Evidence label
Source: BMC pediatrics. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Causes & What We KnowA New Material Design Aims to Keep Transplanted Insulin-Producing Cells AlivePubMed indexed literature
- Causes & What We KnowWhat Matters More for Heart Health in Type 1 Diabetes: Liver Fat or Body Composition?PubMed indexed literature
- Causes & What We KnowNew Study Examines Two Environmental Triggers in Type 1 DiabetesPubMed indexed literature
- Causes & What We KnowDoes Winter Bring More Cases of Diabetic Ketoacidosis? What New Research ShowsPubMed indexed literature
- Causes & What We KnowWhat Thiols Tell Us About Type 1 Diabetes Complications in ChildrenPubMed indexed literature
- Causes & What We KnowA Molecule Called miR-30d-5p Shows Promise in Supporting Beta Cell RecoveryPubMed indexed literature